Nissha Co.ltd. · TSE:7915
Nissha Co.ltd — FY2024 Q3 Earnings Presentation
15 slides from Nissha Co.ltd's earnings presentation, Nov 8, 2024
Slide 1: Financial Results for FY2024 Q3
Financial Results for FY2024 Q3 Ended September 30, 2024 November 8, 2024 Junya Suzuki President and CEO Nissha Co., Ltd.
Slide 2: Highlights
Highlights FY2024 Q3 Results (9 months) ⚫ Tailwinds ⚫ Increased in net sales and profit YoY in all businesses, demand recovered and profitability improved ⚫ Headwinds ⚫ Devices: Demand for high-end models of tablet devices declined in Q3 ⚫ Due to the rapid appreciation of JPY, foreign exchange losse
Slide 3: FY2024 Q3 (9 months) Results
FY2024 Q3 (9 months) Results (Millions of JPY) 2023 Q3 2024 Q3 Results Results YoY Net Sales 123,885 148,402 +19.8% Industrial Materials 51,033 55,314 +8.4% Devices 40,985 53,380 +30.2% Medical Technologies 26,255 33,638 +28.1% Others 5,610 6,068 +8.2% Operating profit -414 6,110 Turn positive Opera
Slide 4: FY2024 Q3 (3 months) Results
FY2024 Q3 (3 months) Results The businesses progressed as expected Foreign exchange loss of 2.3 billion yen due to revaluation with end-of-period rate (a loss of 0.7 billion yen in Operating profit and a loss of 1.6 billion yen to Profit before tax) were recorded (Millions of JPY) 2023 Q3 2024 Q2 20
Slide 5: Industrial Materials
Industrial Materials Quarterly net sales and operating profit margin ⚫ Q3 Results (QoQ) ■Sustainable Materials ●Operating profit margin (Metallized paper and others) ●Operating profit margin ⚫ Net sales ■Decoration (Home appliances (excluding impairment loss) ⚫ Decoration (Mobility): Demand and othe
Slide 6: Acquired Cathtek, LLC (USA), a manufacturer of injection molded parts for medical devices
Industrial Materials Acquired Cathtek, LLC (USA), a manufacturer of injection molded parts for medical devices ⚫ Toward our Sustainability Vision (2030), company- Cathtek, LLC overview wide efforts to be taken to tackle the medical market Headquarters North Carolina, USA ⚫ Strengthen molding busines
Slide 7: Devices
Devices Quarterly net sales and operating profit margin ■Gaming devices, Handheld terminals (logistics related), ⚫Q3 Results (QoQ) Mobility, Gas sensors and others ■Tablet devices ●Operating profit margin ⚫ Net sales ■Smartphones ⚫ Tablet devices: High-end 19,704 (Millions of JPY) 17,106 models drop
Slide 8: Medical Technologies
Medical Technologies ⚫ Q3 Results (QoQ) Quarterly net sales and operating profit margin ⚫ Net sales ⚫ Medical devices (CDMO): Overall ■Business media ●Operating profit margin remained stable though demand ■Medical devices (Own brand) from some customers decreased ■Medical devices (CDMO) 11,954 11,61
Slide 9: Forecast revised
Forecast revised Reflected temporary losses such as foreign exchange losses that occurred in Q3 Sales and operating profit for each business remain unchanged (Millions of JPY) Previous Forecast (August 6) Revised Forecast (November 8) FY2024 FY2024 FY2024 FY2024 FY2024 FY2024 Full-year H1 H2 Full-ye
Slide 10: Prospects for 2025 (next year)
Prospects for 2025 (next year) Demand for non-IT devices to be increased Business Products Markets Demand trend (vs. 2024 forecast) Industrial Decoration Mobility Interior: Solid demand continues Materials (Interior/exterior Exterior: Mass production of a new products begins decoration) (2nd half of
Slide 11: The 8th Medium-term Business Plan: Capital allocation and shareholder returns
The 8th Medium-term Business Plan Slide from the presentation released on February 28, 2024 Capital allocation and shareholder returns Cash-in Cash-out 000 Cash-in Cash-out ⚫ Sale of non-operating assets ⚫ Reduction of strategic ⚫ M&A Sale of Shareholder shareholdings, etc. 000 non-operating returns
Slide 12: Reduction of strategic shareholdings, executed
Reduction of strategic shareholdings, executed ⚫Amount: 8.1 billion yen ⚫Ratio to total equity, 5.7%, at the end of September 2024 ⚫Devote to growth investments and shareholder returns ■Balance of strategic shareholdings ●Ratio to total equity (Millions of JPY) Increase due to (%) 19,277 share price
Slide 13: Acquisition of treasury stock
Acquisition of treasury stock ⚫Reasons for acquisition: To improve shareholder return and capital efficiency Acquisition completed New acquisition Type of shares to be Common stock in Nissha Co., Ltd. Common stock in Nissha Co., Ltd. acquired Market purchase on the Tokyo Market purchase on the Tokyo
Slide 14: (Reference) Capital investment, Depreciation and amortization, M&A investment, R&D (FY2024)
(Reference) Capital investment, Depreciation and amortization, M&A investment, R&D (FY2024) (Millions of JPY) Q1 Results Q2 Results Q3 Results Capital 2,043 2,808 2,601 investment Depreciation and 2,269 2,444 2,327 amortization M&A investment 10,218 540 0 R&D 1,086 1,137 1,071 ©2024 Nissha Group 14
Slide 15: Among the information included in this presentation and provided at investor briefings and conferences,
Among the information included in this presentation and provided at investor briefings and conferences, performance targets, plans, outlooks, strategies and other information that is not constituted of actual past facts, is information that has been judged reasonable by the managers of the Company b